Medios AG announced the closure of its Aschaffenburg facility, a wholly owned subsidiary, as part of an optimization of its manufacturing network. Production has been relocated to other sites within the company's Germany-wide network, and supplies to pharmacies and hospitals remain uninterrupted. The Aschaffenburg site accounted for approximately 10% of the Medios Group's German production volume. The measure affects 32 employees, for whom Medios is seeking to provide fair compensation.
The decision comes as the business of patient-specific formulations faces sustained margin pressure, particularly due to price regulatory adjustments. Medios operates a network of six GMP (Good Manufacturing Practice) manufacturing facilities for patient-specific therapies in Germany. The Aschaffenburg site had been operating at below-average profitability amid declining capacity utilization, making continued economic operation unfeasible. Structural renovation work required at the site accelerated the implementation of this decision.
The site closure is part of the company's Operational Excellence Program, which aims to sustainably strengthen profitability. Thomas Meier, CEO of Medios AG, stated, "With a view to ensuring a reliable supply for our customers and maintaining capacity utilization at all sites, we are now optimizing our successful regional presence strategy and consistently developing it further. With Mannheim and Stuttgart, we have two high-performing Medios sites in southern Germany, ensuring that a reliable supply is maintained."
Medios AG is a leading provider of Specialty Pharma in Europe, with locations in Germany, the Netherlands, Belgium, and Spain. The company supports key partners in the supply chain with innovative solutions and intelligent services, focusing on pioneering individualized medicine to make the most innovative therapies available. Medios shares are listed on the regulated market of the Frankfurt Stock Exchange (Prime Standard) and are included in the SDAX selection index. More information can be found at medios.group.
Important upcoming events for the Medios Group include the Half-Year Financial Report on August 12, 2026, the Berenberg and Goldman Sachs 15th German Corporate Conference from September 21 to 23, the Medios Capital Markets Day on September 28/29, and the Quarterly Statement on November 10, 2026. The original release is available at newmediawire.com.
